Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH14 DNAH17 KIFC3 DNAH11	2.80e-06	18	113	4	GO:0008569
GeneOntologyMolecularFunction	dystroglycan binding	DAG1 DMD VCL	3.74e-05	12	113	3	GO:0002162
GeneOntologyCellularComponent	nuclear pore outer ring	NUP85 NUP160 SEC13	1.89e-05	10	115	3	GO:0031080
GeneOntologyCellularComponent	postsynaptic membrane	GABRP SUSD4 HTR3A DAG1 GRM3 CHRNA7 CHRND LRRTM4 DGKI DMD	8.15e-05	405	115	10	GO:0045211
GeneOntologyCellularComponent	costamere	DAG1 DMD VCL	2.31e-04	22	115	3	GO:0043034
GeneOntologyCellularComponent	synaptic membrane	GABRP SUSD4 HTR3A DAG1 GRM3 CHRNA7 CHRND LRRTM4 MTMR2 DGKI DMD	3.75e-04	583	115	11	GO:0097060
Domain	NCD3G	CASR GRM3 TAS1R1	5.75e-05	13	112	3	PF07562
Domain	GPCR_3_9-Cys_dom	CASR GRM3 TAS1R1	5.75e-05	13	112	3	IPR011500
Domain	GPCR_3_CS	CASR GRM3 TAS1R1	7.28e-05	14	112	3	IPR017979
Domain	Ppantetheine_attach_site	FASN ALDH1L2	1.07e-04	3	112	2	IPR006162
Domain	Neurotransmitter_ion_chnl_CS	GABRP HTR3A CHRNA7 CHRND	1.51e-04	45	112	4	IPR018000
Domain	Neur_chan_memb	GABRP HTR3A CHRNA7 CHRND	1.65e-04	46	112	4	PF02932
Domain	Neurotrans-gated_channel_TM	GABRP HTR3A CHRNA7 CHRND	1.79e-04	47	112	4	IPR006029
Domain	-	GABRP HTR3A CHRNA7 CHRND	1.79e-04	47	112	4	2.70.170.10
Domain	Neur_chan_LBD	GABRP HTR3A CHRNA7 CHRND	1.79e-04	47	112	4	PF02931
Domain	NEUROTR_ION_CHANNEL	GABRP HTR3A CHRNA7 CHRND	1.79e-04	47	112	4	PS00236
Domain	Neur_channel	GABRP HTR3A CHRNA7 CHRND	1.79e-04	47	112	4	IPR006201
Domain	Neur_chan_lig-bd	GABRP HTR3A CHRNA7 CHRND	1.79e-04	47	112	4	IPR006202
Domain	-	FSTL5 EML6 BIRC6 WDR38 WDR12 WDR73 EIF3B HERC1 SEC13	1.79e-04	333	112	9	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	FSTL5 EML6 BIRC6 WDR38 WDR12 WDR73 EIF3B HERC1 SEC13	1.88e-04	335	112	9	IPR015943
Domain	GPCR_3	CASR GRM3 TAS1R1	2.58e-04	21	112	3	IPR000337
Domain	7tm_3	CASR GRM3 TAS1R1	2.97e-04	22	112	3	PF00003
Domain	G_PROTEIN_RECEP_F3_2	CASR GRM3 TAS1R1	2.97e-04	22	112	3	PS00980
Domain	G_PROTEIN_RECEP_F3_3	CASR GRM3 TAS1R1	2.97e-04	22	112	3	PS00981
Domain	G_PROTEIN_RECEP_F3_1	CASR GRM3 TAS1R1	2.97e-04	22	112	3	PS00979
Domain	G_PROTEIN_RECEP_F3_4	CASR GRM3 TAS1R1	2.97e-04	22	112	3	PS50259
Domain	GPCR_3_C	CASR GRM3 TAS1R1	2.97e-04	22	112	3	IPR017978
Domain	-	HTR3A CHRNA7 CHRND	3.41e-04	23	112	3	1.20.120.370
Domain	Acetylcholine_rcpt_TM	HTR3A CHRNA7 CHRND	3.41e-04	23	112	3	IPR027361
Domain	-	FASN ALDH1L2	3.52e-04	5	112	2	1.10.1200.10
Domain	PHOSPHOPANTETHEINE	FASN ALDH1L2	3.52e-04	5	112	2	PS00012
Domain	PP-binding	FASN ALDH1L2	3.52e-04	5	112	2	PF00550
Domain	ACP_DOMAIN	FASN ALDH1L2	3.52e-04	5	112	2	PS50075
Domain	PP-bd_ACP	FASN ALDH1L2	5.26e-04	6	112	2	IPR009081
Domain	ANF_lig-bd_rcpt	CASR GRM3 TAS1R1	1.41e-03	37	112	3	IPR001828
Domain	ANF_receptor	CASR GRM3 TAS1R1	1.41e-03	37	112	3	PF01094
Domain	WD_REPEATS_1	EML6 WDR38 WDR12 WDR73 EIF3B HERC1 SEC13	1.44e-03	278	112	7	PS00678
Domain	WD_REPEATS_2	EML6 WDR38 WDR12 WDR73 EIF3B HERC1 SEC13	1.47e-03	279	112	7	PS50082
Domain	WD_REPEATS_REGION	EML6 WDR38 WDR12 WDR73 EIF3B HERC1 SEC13	1.47e-03	279	112	7	PS50294
Domain	Peripla_BP_I	CASR GRM3 TAS1R1	1.64e-03	39	112	3	IPR028082
Domain	-	GAK MTMR1 STYXL2 MTMR2	2.28e-03	92	112	4	3.90.190.10
Domain	Kelch_2	KLHDC2 ATRNL1	2.66e-03	13	112	2	IPR011498
Domain	Kelch_2	KLHDC2 ATRNL1	2.66e-03	13	112	2	PF07646
Domain	Prot-tyrosine_phosphatase-like	GAK MTMR1 STYXL2 MTMR2	2.98e-03	99	112	4	IPR029021
Domain	Dynein_heavy_chain_D4_dom	DNAH14 DNAH11	3.09e-03	14	112	2	IPR024317
Domain	Dynein_HC_stalk	DNAH14 DNAH11	3.09e-03	14	112	2	IPR024743
Domain	Myotubularin-like_Pase_dom	MTMR1 MTMR2	3.09e-03	14	112	2	IPR010569
Domain	-	NAGA FUCA2	3.09e-03	14	112	2	2.60.40.1180
Domain	MT	DNAH14 DNAH11	3.09e-03	14	112	2	PF12777
Domain	AAA_8	DNAH14 DNAH11	3.09e-03	14	112	2	PF12780
Domain	PPASE_MYOTUBULARIN	MTMR1 MTMR2	3.09e-03	14	112	2	PS51339
Domain	Myotubularin_fam	MTMR1 MTMR2	3.09e-03	14	112	2	IPR030564
Domain	Myotub-related	MTMR1 MTMR2	3.09e-03	14	112	2	PF06602
Domain	DHC_fam	DNAH14 DNAH11	3.56e-03	15	112	2	IPR026983
Domain	Dynein_heavy	DNAH14 DNAH11	3.56e-03	15	112	2	PF03028
Domain	Glyco_hydro_b	NAGA FUCA2	3.56e-03	15	112	2	IPR013780
Domain	Dynein_heavy_dom	DNAH14 DNAH11	3.56e-03	15	112	2	IPR004273
Domain	Glycoside_hydrolase_SF	NAGA FUCA2 GAA	3.95e-03	53	112	3	IPR017853
Domain	GRAM	MTMR1 MTMR2	4.05e-03	16	112	2	SM00568
Domain	Nicotinic_acetylcholine_rcpt	CHRNA7 CHRND	4.05e-03	16	112	2	IPR002394
Domain	Acyl_Trfase/lysoPLipase	FASN PLA2G4C	4.57e-03	17	112	2	IPR016035
Domain	WD40	EML6 WDR38 WDR12 WDR73 HERC1 SEC13	4.72e-03	259	112	6	PF00400
Domain	WD40	EML6 WDR38 WDR12 WDR73 HERC1 SEC13	5.56e-03	268	112	6	SM00320
Domain	WD40_repeat	EML6 WDR38 WDR12 WDR73 HERC1 SEC13	5.97e-03	272	112	6	IPR001680
Pathway	REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS	CASR GRM3 TAS2R3 TAS1R1 TAS2R20	1.84e-06	37	79	5	MM15067
Pathway	REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS	CASR GRM3 TAS2R3 TAS1R1 TAS2R20	2.41e-06	39	79	5	M793
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ABCC3 NUP85 MYCBP2 POLG ANKLE1 BIRC6 HDAC7 LDLR KANSL3 FASN CANT1 PCNX4 SUMF1 KIFC3 HERC1 EVI5L	8.57e-07	1105	116	16	35748872
Pubmed	Cell-cycle-dependent phosphorylation of the nuclear pore Nup107-160 subcomplex.	NUP85 NUP160 SEC13	2.99e-06	9	116	3	17360435
Pubmed	The repertoire of olfactory C family G protein-coupled receptors in zebrafish: candidate chemosensory receptors for amino acids.	CASR GRM3 TAS1R1	4.26e-06	10	116	3	17156446
Pubmed	The entire Nup107-160 complex, including three new members, is targeted as one entity to kinetochores in mitosis.	NUP85 NUP160 SEC13	4.26e-06	10	116	3	15146057
Pubmed	The discovery of a Werner Helicase Interacting Protein (WHIP) association with the nuclear pore complex.	NUP85 NUP160 SEC13	4.26e-06	10	116	3	20676042
Pubmed	K48- and K63-linked ubiquitin chain interactome reveals branch- and length-specific ubiquitin interactors.	AUP1 PEG10 BIRC6 HDAC7 ALDH1L2 SUMF1 GIGYF2 KIFC3 HERC1 TOP1MT IKBKB	6.00e-06	604	116	11	38803224
Pubmed	α-Dystroglycan hypoglycosylation affects cell migration by influencing β-dystroglycan membrane clustering and filopodia length: A multiscale confocal microscopy analysis.	DAG1 DMD	1.10e-05	2	116	2	28572004
Pubmed	Structure of a WW domain containing fragment of dystrophin in complex with beta-dystroglycan.	DAG1 DMD	1.10e-05	2	116	2	10932245
Pubmed	Disruption of sarcolemmal dystrophin and beta-dystroglycan may be a potential mechanism for myocardial dysfunction in severe sepsis.	DAG1 DMD	1.10e-05	2	116	2	20142806
Pubmed	IKKβ links vascular inflammation to obesity and atherosclerosis.	LDLR IKBKB	1.10e-05	2	116	2	24799533
Pubmed	NF-κB inhibition rescues cardiac function by remodeling calcium genes in a Duchenne muscular dystrophy model.	DMD IKBKB	1.10e-05	2	116	2	30143619
Pubmed	The structure of the scaffold nucleoporin Nup120 reveals a new and unexpected domain architecture.	NUP85 NUP160	1.10e-05	2	116	2	19576787
Pubmed	Exogenous Dp71 restores the levels of dystrophin associated proteins but does not alleviate muscle damage in mdx mice.	DAG1 DMD	1.10e-05	2	116	2	7894483
Pubmed	The WW domain of dystrophin requires EF-hands region to interact with beta-dystroglycan.	DAG1 DMD	1.10e-05	2	116	2	10355629
Pubmed	Dystroglycan Mediates Clustering of Essential GABAergic Components in Cerebellar Purkinje Cells.	DAG1 DMD	1.10e-05	2	116	2	32982691
Pubmed	Lack of dystrophin leads to the selective loss of superior cervical ganglion neurons projecting to muscular targets in genetically dystrophic mdx mice.	DAG1 DMD	1.10e-05	2	116	2	16023353
Pubmed	What do mouse models of muscular dystrophy tell us about the DAPC and its components?	DAG1 DMD	1.10e-05	2	116	2	25270874
Pubmed	Desensitization characteristics of the human alpha7nAChR/5HT3A chimera receptor.	HTR3A CHRNA7	1.10e-05	2	116	2	17192651
Pubmed	Preventing phosphorylation of dystroglycan ameliorates the dystrophic phenotype in mdx mouse.	DAG1 DMD	1.10e-05	2	116	2	22810924
Pubmed	Role of mental retardation-associated dystrophin-gene product Dp71 in excitatory synapse organization, synaptic plasticity and behavioral functions.	DAG1 DMD	1.10e-05	2	116	2	19649270
Pubmed	Exogenous Dp71 is a dominant negative competitor of dystrophin in skeletal muscle.	DAG1 DMD	1.10e-05	2	116	2	12398834
Pubmed	Functional implication of Dp71 in osmoregulation and vascular permeability of the retina.	DAG1 DMD	1.10e-05	2	116	2	19809515
Pubmed	Identification and characterization of the dystrophin anchoring site on beta-dystroglycan.	DAG1 DMD	1.10e-05	2	116	2	7592992
Pubmed	Dystroglycan contributes to the formation of multiple dystrophin-like complexes in brain.	DAG1 DMD	1.10e-05	2	116	2	11520903
Pubmed	SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.	NUP85 FAN1 AATF EIF3B TOP1MT NUP160 VCL	2.18e-05	250	116	7	33536335
Pubmed	HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways.	CAD NUP85 AUP1 MTMR1 BIRC6 FASN WDR73 EIF3B NUP160 SEC13	2.26e-05	571	116	10	37167062
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	NUP85 PEG10 DPP8 BIRC6 LAP3 FASN JMJD6 PSMG1 MTMR2 WDR12 EIF3B HERC1 IKBKB NUP160 VCL SEC13	2.73e-05	1455	116	16	22863883
Pubmed	A synthetic interaction screen identifies factors selectively required for proliferation and TERT transcription in p53-deficient human cancer cells.	ARPP21 LAP3 EPG5 SACS JMJD8	2.80e-05	105	116	5	23284306
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	CPA4 GAK CAD HSP90AB4P MYCBP2 PEG10 BIRC6 LDLR FASN TMTC3 PSMG1 WDR12 IKBKB NUP160 GAA	2.80e-05	1297	116	15	33545068
Pubmed	N-terminal α Dystroglycan (αDG-N): A Potential Serum Biomarker for Duchenne Muscular Dystrophy.	DAG1 DMD	3.30e-05	3	116	2	27854211
Pubmed	A new look at cytoskeletal NOS-1 and β-dystroglycan changes in developing muscle and brain in control and mdx dystrophic mice.	DAG1 DMD	3.30e-05	3	116	2	23940011
Pubmed	Selective activation of α7 nicotinic acetylcholine receptor (nAChRα7) inhibits muscular degeneration in mdx dystrophic mice.	CHRNA7 DMD	3.30e-05	3	116	2	24833065
Pubmed	α7 Nicotinic acetylcholine receptor is expressed in human atherosclerosis and inhibits disease in mice--brief report.	LDLR CHRNA7	3.30e-05	3	116	2	25324572
Pubmed	Utrophin A is essential in mediating the functional adaptations of mdx mouse muscle following chronic AMPK activation.	DAG1 DMD	3.30e-05	3	116	2	25324540
Pubmed	Dystroglycan is not required for localization of dystrophin, syntrophin, and neuronal nitric-oxide synthase at the sarcolemma but regulates integrin alpha 7B expression and caveolin-3 distribution.	DAG1 DMD	3.30e-05	3	116	2	11741881
Pubmed	Dual role of the RIC-3 protein in trafficking of serotonin and nicotinic acetylcholine receptors.	HTR3A CHRNA7	3.30e-05	3	116	2	15927954
Pubmed	Drastic reduction of sarcalumenin in Dp427 (dystrophin of 427 kDa)-deficient fibres indicates that abnormal calcium handling plays a key role in muscular dystrophy.	DAG1 DMD	3.30e-05	3	116	2	14678011
Pubmed	Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice.	DAG1 DMD	3.30e-05	3	116	2	1757468
Pubmed	Fxr1 knockout mice show a striated muscle phenotype: implications for Fxr1p function in vivo.	DMD VCL	3.30e-05	3	116	2	15128702
Pubmed	Deletion of Galgt2 (B4Galnt2) reduces muscle growth in response to acute injury and increases muscle inflammation and pathology in dystrophin-deficient mice.	DAG1 DMD	3.30e-05	3	116	2	26435413
Pubmed	Platelet IκB kinase-β deficiency increases mouse arterial neointima formation via delayed glycoprotein Ibα shedding.	LDLR IKBKB	3.30e-05	3	116	2	23241410
Pubmed	Intermittent hypoxia and hypercapnia induces inhibitor of nuclear factor-κB kinase subunit β-dependent atherosclerosis in pulmonary arteries.	LDLR IKBKB	3.30e-05	3	116	2	31618063
Pubmed	Myeloid-specific IκB kinase β deficiency decreases atherosclerosis in low-density lipoprotein receptor-deficient mice.	LDLR IKBKB	3.30e-05	3	116	2	23023371
Pubmed	Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice.	LDLR IKBKB	3.30e-05	3	116	2	14561702
Pubmed	Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle.	DMD GAA	3.30e-05	3	116	2	20413686
Pubmed	Reduced size and macrophage content of advanced atherosclerotic lesions in mice with bone marrow specific deficiency of alpha 7 nicotinic acetylcholine receptor.	LDLR CHRNA7	3.30e-05	3	116	2	25826262
Pubmed	Mouse Model of Chromosome 15q13.3 Microdeletion Syndrome Demonstrates Features Related to Autism Spectrum Disorder.	CHRNA7 FAN1	3.30e-05	3	116	2	26658876
Pubmed	Phosphorylation within the cysteine-rich region of dystrophin enhances its association with β-dystroglycan and identifies a potential novel therapeutic target for skeletal muscle wasting.	DAG1 DMD	3.30e-05	3	116	2	25082828
Pubmed	Dystroglycan mRNA expression during normal and mdx mouse embryogenesis: a comparison with utrophin and the apo-dystrophins.	DAG1 DMD	3.30e-05	3	116	2	8589441
Pubmed	Hematopoietic α7 nicotinic acetylcholine receptor deficiency increases inflammation and platelet activation status, but does not aggravate atherosclerosis.	LDLR CHRNA7	3.30e-05	3	116	2	25345495
Pubmed	Archvillin, a muscle-specific isoform of supervillin, is an early expressed component of the costameric membrane skeleton.	DMD VCL	3.30e-05	3	116	2	12711699
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	CAD NUP85 RBL1 TMEM214 FASN COG1 PCNX4 IRAG2 DMD NUP160 SEC13	4.62e-05	754	116	11	35906200
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	ABCC3 STIM2 MYCBP2 NAGA DAG1 ALG11 TMEM214 LDLR TMTC3 CANT1 PSMG1 JMJD8 SUMF1 FUCA2	4.86e-05	1201	116	14	35696571
Pubmed	Syntrophin-dependent expression and localization of Aquaporin-4 water channel protein.	DAG1 DMD	6.59e-05	4	116	2	11717465
Pubmed	Local proliferation dominates lesional macrophage accumulation in atherosclerosis.	LDLR CSF2RB	6.59e-05	4	116	2	23933982
Pubmed	Functional redundancy in the myotubularin family.	MTMR1 MTMR2	6.59e-05	4	116	2	11846405
Pubmed	Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities.	DAG1 DMD	6.59e-05	4	116	2	11259414
Pubmed	Dystroglycan is selectively associated with inhibitory GABAergic synapses but is dispensable for their differentiation.	DAG1 DMD	6.59e-05	4	116	2	12040032
Pubmed	Myotubularins, a large disease-associated family of cooperating catalytically active and inactive phosphoinositides phosphatases.	MTMR1 MTMR2	6.59e-05	4	116	2	12925573
Pubmed	Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk.	CSF2RB DGKI	6.59e-05	4	116	2	19065143
Pubmed	Mutations in multiple components of the nuclear pore complex cause nephrotic syndrome.	NUP85 NUP160	6.59e-05	4	116	2	30179222
Pubmed	Notch enhances Ca2+ entry by activating calcium-sensing receptors and inhibiting voltage-gated K+ channels.	STIM2 CASR	6.59e-05	4	116	2	32186932
Pubmed	Plectin 1f scaffolding at the sarcolemma of dystrophic (mdx) muscle fibers through multiple interactions with beta-dystroglycan.	DAG1 DMD	6.59e-05	4	116	2	17389230
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	CAD MYCBP2 BIRC6 FASN GIGYF2 AATF WDR12 NUP160 VCL SEC13	6.96e-05	653	116	10	22586326
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	EML6 MTMR1 TEK LRRTM4 MTMR2 GIGYF2 EIF3B HERC1	8.63e-05	420	116	8	28065597
Pubmed	BCR-Induced Ca2+ Signals Dynamically Tune Survival, Metabolic Reprogramming, and Proliferation of Naive B Cells.	STIM2 IKBKB	1.10e-04	5	116	2	32294437
Pubmed	Role of dystrophins and utrophins in platelet adhesion process.	DMD VCL	1.10e-04	5	116	2	16803572
Pubmed	Foot pad skin biopsy in mouse models of hereditary neuropathy.	DAG1 MTMR2	1.10e-04	5	116	2	20878767
Pubmed	Dp71 gene disruption alters the composition of the dystrophin-associated protein complex and neuronal nitric oxide synthase expression in the hypothalamic supraoptic and paraventricular nuclei.	DAG1 DMD	1.10e-04	5	116	2	22493004
Pubmed	Specific disruption of a schwann cell dystrophin-related protein complex in a demyelinating neuropathy.	DAG1 DMD	1.10e-04	5	116	2	11430802
Pubmed	An ankyrin-based mechanism for functional organization of dystrophin and dystroglycan.	DAG1 DMD	1.10e-04	5	116	2	19109891
Pubmed	Genetic susceptibility to accelerated cognitive decline in the US Health and Retirement Study.	DGKI DNAH11	1.10e-04	5	116	2	24468470
Pubmed	Expression of the dystrophin-glycoprotein complex is a marker for human airway smooth muscle phenotype maturation.	DAG1 DMD	1.10e-04	5	116	2	17993586
Pubmed	A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast.	MTMR1 MTMR2	1.10e-04	5	116	2	8640223
Pubmed	NF-κB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia.	DMD IKBKB	1.10e-04	5	116	2	24084740
Pubmed	Dystroglycan mediates homeostatic synaptic plasticity at GABAergic synapses.	DAG1 DMD	1.10e-04	5	116	2	24753587
Pubmed	Integrated structural analysis of the human nuclear pore complex scaffold.	NUP85 NUP160 SEC13	1.37e-04	30	116	3	24315095
Pubmed	The Structure Inventory of the Nuclear Pore Complex.	NUP85 NUP160 SEC13	1.37e-04	30	116	3	27016207
Pubmed	Maternal synchronization of gestational length and lung maturation.	ABCA3 TEK FASN	1.52e-04	31	116	3	22096492
Pubmed	Fukutin-related protein associates with the sarcolemmal dystrophin-glycoprotein complex.	DAG1 DMD	1.64e-04	6	116	2	17452335
Pubmed	Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy.	DMD IKBKB	1.64e-04	6	116	2	17380205
Pubmed	TNF inhibits Notch-1 in skeletal muscle cells by Ezh2 and DNA methylation mediated repression: implications in duchenne muscular dystrophy.	DMD IKBKB	1.64e-04	6	116	2	20814569
Pubmed	Mitofusins regulate lipid metabolism to mediate the development of lung fibrosis.	POLG FASN	1.64e-04	6	116	2	31358769
Pubmed	Che-1 affects cell growth by interfering with the recruitment of HDAC1 by Rb.	RBL1 AATF	1.64e-04	6	116	2	12450794
Pubmed	Expression of the dystrophin-related protein 2 (Drp2) transcript in the mouse.	DAG1 DMD	1.64e-04	6	116	2	9245586
Pubmed	15q13.3 Recurrent Deletion	CHRNA7 FAN1	1.64e-04	6	116	2	21290787
Pubmed	Interactions between dystrophin glycoprotein complex proteins.	DAG1 DMD	1.64e-04	6	116	2	7547961
Pubmed	Dystrophin stabilizes alpha 3- but not alpha 7-containing nicotinic acetylcholine receptor subtypes at the postsynaptic apparatus in the mouse superior cervical ganglion.	CHRNA7 DMD	1.64e-04	6	116	2	12079404
Pubmed	GMCSF activates NF-kappaB via direct interaction of the GMCSF receptor with IkappaB kinase beta.	CSF2RB IKBKB	1.64e-04	6	116	2	12637324
Pubmed	Contribution of the different modules in the utrophin carboxy-terminal region to the formation and regulation of the DAP complex.	DAG1 DMD	1.64e-04	6	116	2	10767429
Pubmed	Venus trap in the mouse embryo reveals distinct molecular dynamics underlying specification of first embryonic lineages.	NUP85 POLG ITPKC	1.67e-04	32	116	3	26142281
Pubmed	Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes.	CAD MYCBP2 HERC1 IKBKB	1.93e-04	85	116	4	16051665
Pubmed	Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.	CAD NUP85 AUP1 NAGA TMEM214 FASN EIF3B FUCA2 GAA	2.22e-04	613	116	9	22268729
Pubmed	Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle.	DAG1 DMD	2.29e-04	7	116	2	1461282
Pubmed	Phosphoinositide 3-kinase p85beta regulates invadopodium formation.	PIK3R2 VCL	2.29e-04	7	116	2	25217619
Pubmed	CFAP45 deficiency causes situs abnormalities and asthenospermia by disrupting an axonemal adenine nucleotide homeostasis module.	DNAH17 DNAH11	2.29e-04	7	116	2	33139725
Pubmed	Transcriptional repression of atherogenic inflammation: modulation by PPARdelta.	HDAC7 LDLR	2.29e-04	7	116	2	12970571
Pubmed	Embryo implantation in mouse: fetomaternal coordination in the pattern of expression of uPA, uPAR, PAI-1 and alpha 2MR/LRP genes.	TEK LDLR	2.29e-04	7	116	2	8798151
Pubmed	The cellular prion protein colocalizes with the dystroglycan complex in the brain.	DAG1 DMD	2.29e-04	7	116	2	11032878
Pubmed	Talin1 has unique expression versus talin 2 in the heart and modifies the hypertrophic response to pressure overload.	DMD VCL	2.29e-04	7	116	2	23266827
Cytoband	Ensembl 112 genes in cytogenetic band chr17q25	NUP85 LRRC45 FASN COG1 CANT1 JMJD6 DNAH17 GAA	1.24e-06	307	116	8	chr17q25
Cytoband	Ensembl 112 genes in cytogenetic band chr19p13	SIN3B CPAMD8 ACER1 ZNF559 ANKLE1 TMEM205 LDLR PIK3R2 EVI5L	2.00e-04	797	116	9	chr19p13
GeneFamily	Dyneins, axonemal	DNAH14 DNAH17 DNAH11	4.12e-05	17	73	3	536
GeneFamily	Nucleoporins	NUP85 NUP160 SEC13	2.88e-04	32	73	3	1051
GeneFamily	WD repeat domain containing	EML6 WDR38 WDR12 WDR73 HERC1 SEC13	6.61e-04	262	73	6	362
GeneFamily	Myotubularins\|Phosphoinositide phosphatases	MTMR1 MTMR2	1.63e-03	15	73	2	903
GeneFamily	Cholinergic receptors nicotinic subunits	CHRNA7 CHRND	1.86e-03	16	73	2	173
GeneFamily	Fibronectin type III domain containing	TEK IGDCC4 CSF2RB CNTFR	4.00e-03	160	73	4	555
Coexpression	GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP	CAD PEG10 DPP8 TMTC3 PIK3R2 NUP160 CNTFR	1.92e-05	187	115	7	M6807
Coexpression	GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_DN	ABCC3 RBL1 FASN IRAG2 IKBKB NUP160 VCL	2.96e-05	200	115	7	M5212
Coexpression	GSE17721_CTRL_VS_POLYIC_12H_BMDC_UP	ABCC3 MYCBP2 POLG MTMR1 FASN FUCA2 HERC1	2.96e-05	200	115	7	M3719
Coexpression	GSE9316_IL6_KO_VS_IFNG_KO_INVIVO_EXPANDED_CD4_TCELL_UP	ABCC3 ABCA3 SUMF1 IRAG2 FUCA2 DMD VCL	2.96e-05	200	115	7	M6888
ToppCell	3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-DZ_GC_cell\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HTR3A PEG10 EML6 C3orf20 CHRND IRAG2	4.25e-06	162	116	6	3e15b3e97a2ade86d0cb0ab15fccb9a2e2e27dd4
ToppCell	droplet-Limb_Muscle-nan-3m-Myeloid-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EML6 CSF2RB IRAG2 DGKI LY75 EDRF1	4.89e-06	166	116	6	0a7992bc673fca546636563ec3fc17a4298ab6b1
ToppCell	PND01-03-samps-Mesenchymal-Pericyte-pericyte_F\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	CPA4 CHST5 SERPINE3 CAD FJX1 PQBP1	5.60e-06	170	116	6	71718dcebd48105994c313bb55babc70301170a0
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	C2orf69 DAG1 ANKRD50 BIRC6 GIGYF2 CPLANE1	1.16e-05	193	116	6	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	PEG10 DAG1 CHRND IGDCC4 TMEM47 DMD	1.38e-05	199	116	6	e19b296d583f8bad3b66ee998a8153634d6fe09e
ToppCell	10x3'2.3-week_17-19-Mesenchymal_myocytic\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	PEG10 DAG1 CHRND IGDCC4 TMEM47 DMD	1.38e-05	199	116	6	801887db51ac5dc5b068808ff75e3a46643398e9
ToppCell	Macroglial-Polydendrocytes-PDGFRA-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SUSD4 ARPP21 TEK ATRNL1 LRRTM4 DGKI	1.41e-05	200	116	6	f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2
ToppCell	Macroglial-Polydendrocytes-PDGFRA--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SUSD4 ARPP21 TEK ATRNL1 LRRTM4 DGKI	1.41e-05	200	116	6	cc3409518f8b436ea92deb955e81114b3f410ff7
ToppCell	Macroglial-Polydendrocytes-PDGFRA\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SUSD4 ARPP21 TEK ATRNL1 LRRTM4 DGKI	1.41e-05	200	116	6	c24a3099e3d96d8b72f6d05286bb355d661a0377
ToppCell	Macroglial-Polydendrocytes-PDGFRA---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SUSD4 ARPP21 TEK ATRNL1 LRRTM4 DGKI	1.41e-05	200	116	6	4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca
ToppCell	Macroglial-Polydendrocytes-PDGFRA----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SUSD4 ARPP21 TEK ATRNL1 LRRTM4 DGKI	1.41e-05	200	116	6	310cd53db1c137f6af74e6ae682221d7ac27310c
ToppCell	Macroglial-Polydendrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SUSD4 ARPP21 TEK ATRNL1 LRRTM4 DGKI	1.41e-05	200	116	6	961858738ce35db8760c8c2e136f8369bc444ccf
Disease	Duchenne muscular dystrophy (is_implicated_in)	DAG1 DMD	3.90e-05	3	107	2	DOID:11723 (is_implicated_in)
Disease	Cardiomyopathies	POLG EPG5 DMD GAA VCL	1.14e-04	130	107	5	C0878544
Disease	Duchenne muscular dystrophy (is_marker_for)	DAG1 DMD	1.29e-04	5	107	2	DOID:11723 (is_marker_for)
Disease	pulmonary alveolar proteinosis (implicated_via_orthology)	ABCA3 CSF2RB	1.29e-04	5	107	2	DOID:12120 (implicated_via_orthology)
Disease	acute kidney tubular necrosis (biomarker_via_orthology)	TEK BMP7	1.29e-04	5	107	2	DOID:12556 (biomarker_via_orthology)
Disease	immunoglobulin superfamily DCC subclass member 4 measurement	DPP8 IGDCC4	1.29e-04	5	107	2	EFO_0801690
Disease	Mental deterioration	TEK DGKI DNAH11	1.58e-04	29	107	3	HP_0001268
Disease	muscular atrophy (biomarker_via_orthology)	HSP90AB4P DAG1 DMD	1.58e-04	29	107	3	DOID:767 (biomarker_via_orthology)
Disease	NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE	NUP85 NUP160 PLCE1	1.75e-04	30	107	3	C1868672
Disease	brain disease (implicated_via_orthology)	STIM2 MYCBP2	1.94e-04	6	107	2	DOID:936 (implicated_via_orthology)
Disease	pulmonary alveolar proteinosis (is_implicated_in)	ABCA3 CSF2RB	1.94e-04	6	107	2	DOID:12120 (is_implicated_in)
Disease	worry measurement	ARPP21 TMEM241 MYCBP2 GRM3 MTMR2	2.51e-04	154	107	5	EFO_0009589
Disease	Ventricular Dysfunction	DMD GAA	3.60e-04	8	107	2	C0242973
Disease	centronuclear myopathy X-linked (implicated_via_orthology)	MTMR1 MTMR2	4.61e-04	9	107	2	DOID:0111225 (implicated_via_orthology)
Disease	hepatocellular carcinoma (biomarker_via_orthology)	ABCC3 CAD TEK PIK3R2	6.56e-04	108	107	4	DOID:684 (biomarker_via_orthology)
Disease	urokinase-type plasminogen activator measurement	LY75 VCL	7.01e-04	11	107	2	EFO_0010803
Disease	Cardiomyopathy, Dilated	FASN WDR12 DMD	7.12e-04	48	107	3	C0007193
Disease	developmental disorder of mental health (implicated_via_orthology)	GABRP SIN3B GIGYF2	7.57e-04	49	107	3	DOID:0060037 (implicated_via_orthology)
Disease	Cardiomyopathy, Familial Idiopathic	FASN WDR12 DMD	8.03e-04	50	107	3	C1449563
Disease	Colorectal Carcinoma	ABCC3 CPAMD8 ABCA3 CAD FSTL5 PQBP1 SACS DMD EDRF1	1.05e-03	702	107	9	C0009402
Disease	urokinase plasminogen activator surface receptor measurement	LY75 VCL	1.15e-03	14	107	2	EFO_0010932
Disease	Hypertrophic Cardiomyopathy	FASN GAA VCL	1.18e-03	57	107	3	C0007194
Disease	mitochondrial DNA measurement	SERPINE3 POLG ANKLE1 LDLR TOP1MT LY75	1.27e-03	328	107	6	EFO_0006312
Disease	cortex volume change measurement	SUMF1 LRRTM4	1.33e-03	15	107	2	EFO_0021500
Disease	non-lobar intracerebral hemorrhage	DNAH14 WDR12 NUP160	1.57e-03	63	107	3	EFO_0010178
Disease	attention deficit hyperactivity disorder, schizophrenia	GRM3 DGKI GIGYF2	1.64e-03	64	107	3	EFO_0003888, MONDO_0005090
Disease	cognitive function measurement, self reported educational attainment	ARPP21 MYCBP2 DPP8 BIRC6 MTMR2 NUP160	1.90e-03	355	107	6	EFO_0004784, EFO_0008354
Disease	susceptibility to mononucleosis measurement	ANKRD50 HDAC7 DMD	2.04e-03	69	107	3	EFO_0008403
Disease	thrombin activatable fibrinolysis inhibitor activation peptide measurement	OTOA ARPP21	2.14e-03	19	107	2	EFO_0008582
Disease	cortisol measurement	LDLR BMP7	2.37e-03	20	107	2	EFO_0005843
Disease	kidney disease (biomarker_via_orthology)	ABCC3 BMP7	2.62e-03	21	107	2	DOID:557 (biomarker_via_orthology)
Disease	muscular dystrophy (implicated_via_orthology)	DAG1 DMD	2.62e-03	21	107	2	DOID:9884 (implicated_via_orthology)
Disease	mucocutaneous lymph node syndrome	STIM2 EPG5 ITPKC	2.69e-03	76	107	3	EFO_0004246
Disease	dilated cardiomyopathy (implicated_via_orthology)	STIM2 DAG1 DMD	3.11e-03	80	107	3	DOID:12930 (implicated_via_orthology)
Disease	Epilepsy, Benign Psychomotor, Childhood	GRM3 TEK	3.14e-03	23	107	2	C0393672
Disease	Epilepsy, Lateral Temporal	GRM3 TEK	3.14e-03	23	107	2	C0393682
Disease	Uncinate Epilepsy	GRM3 TEK	3.14e-03	23	107	2	C0014558
Disease	Epilepsy, Temporal Lobe	GRM3 TEK	3.14e-03	23	107	2	C0014556
Disease	Coronary heart disease	LDLR DNAH11	3.41e-03	24	107	2	C0010068
Disease	Charcot-Marie-Tooth disease (implicated_via_orthology)	MTMR1 MTMR2	3.41e-03	24	107	2	DOID:10595 (implicated_via_orthology)
Disease	Nephritis, Interstitial	SLC16A12 FAN1	3.41e-03	24	107	2	C0027707
Disease	Dyslipidemias	LDLR DNAH11	3.41e-03	24	107	2	C0242339
Disease	Dyslipoproteinemias	LDLR DNAH11	3.41e-03	24	107	2	C0598784
Disease	carotid plaque build	EPG5 ATRNL1 LRRTM4	3.57e-03	84	107	3	EFO_0006501

Protein segments in the cluster

Peptide	Gene	Start	Entry
LRWWATSASNDSLLE	nan	121	A8MVM7
VNSSWTLNHILSLWK	ALG11	256	Q2TAA5
SSNLSHLEEDTWILW	EVI5L	76	Q96CN4
NWVSVLSDAWNSSPH	EPG5	2096	Q9HCE0
ETLTTNVWIEHGWTD	CHRND	71	Q07001
WHSWVGALTLLATAV	CYB561D1	126	Q8N8Q1
VVTSVSWWSHKVDNA	EIF3B	666	P55884
WEHQTSIDSDMATLW	ANKLE1	321	Q8NAG6
TWKLQTDSNSWDEHV	BIRC6	1076	Q9NR09
WENWSLENVATILAH	C2orf69	126	Q8N8R5
SVVLWAVALTSWISD	ACER1	176	Q8TDN7
KIWLASEAWASSSLI	CASR	291	P41180
AEISWDQSAEVLHNW	ALDH1L2	231	Q3SY69
WAETLSLDVNSIHWS	GRM3	486	Q14832
TSWLHTIQDINISLW	HTR3A	176	P46098
AIDEQLTAATTWLTW	DNAH11	791	Q96DT5
VHVASFWLSALLWDL	ABCA3	1136	Q99758
HTDQDGWTALRSAAW	ANKRD50	606	Q9ULJ7
NRAWTELTDWLSLLD	DMD	2476	P11532
EGWLVFDITATSNHW	BMP7	221	P18075
SGWLHNTSSWLASSL	BBS12	566	Q6ZW61
NELKWSDHQRAWSST	ARPP21	351	Q9UBL0
VLTTNIWLQMSWTDH	CHRNA7	71	P36544
VHAESNSSTSIWLRW	IGDCC4	756	Q8TDY8
DEARWLSNVDGTHWL	MTMR1	396	Q13613
RTHLEWSWSELETTC	ITPKC	121	Q96DU7
WWALELSHLHTFVSS	ABCC3	1396	O15438
SSWLWNKLFEASIET	LAP3	411	P28838
TDDSASWVSAEHLWV	OTOA	246	Q7RTW8
SSIDTVASLSWQTEW	OTOA	921	Q7RTW8
WWHVVLNLDTTIAIT	JMJD6	271	Q6NYC1
QGLTWTWSSLHNLDL	LRRTM4	246	Q86VH4
ALDWSWLQTEEEEHS	IKBKB	736	O14920
HPAVWDSVNWELSTT	EDRF1	956	Q3B7T1
EDSINWRHLSELLWS	HSP90AB4P	351	Q58FF6
KWLEHLNSSWITEDS	HERC1	11	Q15751
SWLHWDSQSHTLEGL	DAG1	106	Q14118
LIHESACWSDTLQRW	CANT1	281	Q8WVQ1
VSTVHLISSTDIWWN	PCNX4	501	Q63HM2
LISSTDIWWNRSLDT	PCNX4	506	Q63HM2
IALSNWWFVAHLTDL	NUP85	366	Q9BW27
AISSWDWLDISSVNS	POLG	341	P54098
VRWLSTHDPNITWST	PEG10	446	Q86TG7
GLSQHSVDQSWSWLD	LY75	1601	O60449
ETHWLSNLESTHWLE	MTMR2	376	Q13614
IQSLTLEWNSLGTWD	LRRC45	116	Q96CN5
KSHDQVWVLSWGTLE	FSTL5	551	Q8N475
WNADTDLVSWLSPHD	PQBP1	66	O60828
LWNEWCRTTDTTHLS	PSMG1	101	O95456
DWSLSDVDQWDTAAL	PIK3R2	156	O00459
AAHWTEGSVVSLTRW	FJX1	231	Q86VR8
EHTWLTEMLENWTRT	PLA2G4C	306	Q9UP65
HTWRSQNDTVTPDVW	FUCA2	371	Q9BTY2
STLHTVLWDGESRWT	GAK	1236	O14976
SEWSEARSWDTESVL	CSF2RB	426	P32927
MWELLTNESTNHSWD	COG1	386	Q8WTW3
QWASDLVSSIWSNAD	GIGYF2	1056	Q6Y7W6
WVGDISWTHDSLFLA	CPLANE1	316	Q9H799
ISIWFEVQRTWSHLE	DNAH17	1486	Q9UFH2
TLDWSENAVNGEHLW	DGKI	166	O75912
HKWSWTSRTETLLSL	C3orf20	461	Q8ND61
HSREWISQATAIWTA	CPA4	181	Q9UI42
THWSLSNSWDVDKGT	CPAMD8	1346	Q8IZJ3
DWIAFIHSNDIWISN	DPP8	226	Q6V1X1
EIGTWSDWSVAAHAT	CNTFR	286	P26992
VTDELWVFNIHSQSW	ATRNL1	381	Q5VV63
ASWEWRNSSLQSIDV	DNAH14	946	Q0VDD8
STWTVDHQLLWGEAL	GAA	736	P10253
EDSWTSLEHILWPFT	IRAG2	531	Q12912
SWDTKLIQWLHTTLV	KANSL3	186	Q9P2N6
WNDHVHILDTETFTW	KLHDC2	191	Q9Y2U9
VTNVRWSHDFQWVLS	EML6	566	Q6ZMW3
DTIWNELHSSNAARW	HDAC7	626	Q8WUI4
RWLSTSIPEAQWHSS	FASN	711	P49327
ESWLKNAWHFISESV	SACS	3241	Q9NZJ4
LVVLSWVSFWISLDS	GABRP	256	O00591
ESLRAWVAATWHEQE	FAN1	896	Q9Y2M0
WHEQEGRVASLVSWD	FAN1	906	Q9Y2M0
WERASASSWTLEDAT	ARHGAP20	1156	Q9P2F6
WHVSWSITANILAVS	SEC13	266	P55735
NAWAVTNHFSIWLAT	TAS2R20	86	P59543
DVSWTFTNHLSIWLA	TAS2R3	86	Q9NYW6
ILASQHAWAQLTFWE	TMEM205	71	Q6UW68
AVSAWLWSLTSETTL	TMEM191B	311	P0C7N4
HWTANSSKIITWLLE	SLC16A12	6	Q6ZSM3
FNEVSSWVTWLILTA	PLCE1	601	Q9P212
QILESLAWSHDSALW	RBL1	561	P28749
LAWSHDSALWEALQV	RBL1	566	P28749
RAELGSWSSQEHLEW	KIFC3	776	Q9BVG8
EWHSRWLEDNVTVEA	SIN3B	1101	O75182
ESLLSILHWSWTTLV	MYCBP2	1421	O75592
ILHWSWTTLVLGVEE	MYCBP2	1426	O75592
WHWATTQTTQLSLSF	MT-ND5	66	P03915
LTSTDIWALWHDAEN	NUP160	401	Q12769
WTSDWWTVHHSVEET	SUMF1	301	Q8NBK3
TSRKAWNEDHWEQTL	AATF	76	Q9NY61
WHVWTTLSQGSAATL	CHST5	96	Q9GZS9
VSDASWVSELLWSLF	AUP1	201	Q9Y679
GHWEWSCESLESLAV	ZNF135	131	P52742
VWVASEAWALSRHIT	TAS1R1	296	Q7RTX1
SEVHNWTLEDTLQWL	STIM2	131	Q9P246
ESSAWESVSSHDIWV	STYXL2	436	Q5VZP5
EQTWPSTHETLLTTW	SUSD4	306	Q5VX71
SEAVHWTWLCLQDIT	TMEM214	661	Q6NUQ4
RVLQLTSWDEDAWAS	VCL	246	P18206
RSDNTVTWLAAWTES	TOP1MT	241	Q969P6
CFVEHVSWWANSSLE	SERPINE3	126	A8MV23
IWHCESTLSSDWQIA	TMEM47	66	Q9BQJ4
DSSGWATILAVIWLH	VWA5A	721	O00534
AQGEWSEDLTAWTLS	TEK	621	Q02763
LVLLVDFAHSWNESW	SERINC3	176	Q13530
SHWSATRTLHEWLQQ	CAD	96	P27708
HVSWKLGWVEINSSS	TMEM241	51	Q24JQ0
CLATGSWDSTVHIWD	WDR38	161	Q5JTN6
WDHTIRVWDVESGSL	WDR12	276	Q9GZL7
THSLKTFHRNWDWES	TMTC3	416	Q6ZXV5
VAVDWESHINTKWSA	ZNF559	51	Q9BR84
WDLWSVHFTQISLDF	UHRF1BP1	691	Q6BDS2
TNDASLHVWDWVDLC	WDR73	361	Q6P4I2
SILLVATWVTHSSWL	XKR8	296	Q9H6D3
WWHATLNLDTSVFIS	JMJD8	246	Q96S16
VDWIHSNIYWTDSVL	LDLR	481	P01130
HALLRESWEAAQETW	ART5	61	Q96L15
DDIQDSWWSVLSILN	NAGA	216	P17050
SWWSVLSILNWFVEH	NAGA	221	P17050